Hepatitis C drug may reduce antibiotic resistance, researchers say
A hepatitis C drug, telaprevir, can block the function of essential proteins in bacteria, which may allow to it be repurposed to limit antibiotic resistance, a study released Tuesday showed. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 23, 2021 Category: Consumer Health News Source Type: news

Liver Cancer Risk Lingers Even After HCV Eradication Liver Cancer Risk Lingers Even After HCV Eradication
Risk for hepatocellular carcinoma (HCC) is lower for patients who have sustained viral responses after drug therapy for hepatitis C, but this treatment does not cure fibrosis, a common cause of HCC.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 17, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

European CHMP positive opinion for licence extension for Epclusa (sofosbuvir/velpatasvir) in hepatitis C infection
The recommended license extension is for treatment of chronic hepatitis C virus (HCV) infection in patients aged 3 years of age and older. A new granules formulation is recommended for approval. It is currently licensed for patients aged 6 years and over. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 16, 2021 Category: Consumer Health News Source Type: news

Changing Characteristics of Patients With Chronic HCV 2014-2019 Changing Characteristics of Patients With Chronic HCV 2014-2019
During the period 2014-2019, how did patients in Germany with chronic hepatitis C change in terms of demographic and clinical characteristics?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 15, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

A New Algorithm Discriminates Liver Fibrosis Stages in HCV A New Algorithm Discriminates Liver Fibrosis Stages in HCV
The authors present an algorithm utilizing serum levels of siglec-7 as a biomarker to assess liver fibrosis stage in patients with chronic hepatitis C.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 8, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Pfizer Says COVID-19 Pill Cuts Hospital And Death Risk By 90%
(WASHINGTON) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market. Currently all COVID-19 treatments used in the U.S. require an IV or injection. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on Thursday the United Kingdom became the first country to OK it. Pfizer said it will ask the FDA and international regulat...
Source: TIME: Health - November 5, 2021 Category: Consumer Health News Authors: Matthew Perrone/ AP Tags: Uncategorized COVID-19 wire Source Type: news

HCV in Pregnancy: One Piece of a Bigger Problem HCV in Pregnancy: One Piece of a Bigger Problem
Mirroring the opioid crisis, maternal and newborn hepatitis C infections more than doubled in the United States between 2009 and 2019, research shows.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 5, 2021 Category: Gastroenterology Tags: Ob/Gyn & Women ' s Health News Source Type: news

How One Country Reduced HCV in MSM With HIV to Less Than 1% How One Country Reduced HCV in MSM With HIV to Less Than 1%
The US launched its first plan to eliminate hepatitis C in the US this year. Switzerland shows one way to do it.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 3, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Global Cascade of Care for Chronic Hepatitis C Virus Infection Global Cascade of Care for Chronic Hepatitis C Virus Infection
This systematic review assessing data on the HCV care cascade in various countries and populations reveals that DAA treatment uptake in most countries is sub-optimal.Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - October 25, 2021 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

Treating Hepatis C Virus and Opioid Use Disorder Together Benefits Patients
This study found that people with hepatitis C virus (HCV) who inject drugs, offering buprenorphine treatment for opioid use disorder at the same location as HCV treatment resulted in high rates of buprenorphine initiation. People who started and maintained buprenorphine during HCV treatment … (Source: NIDA News)
Source: NIDA News - October 25, 2021 Category: Addiction Tags: Hepatitis, HIV or AIDS, NIDA Notes, Opioids, Treatment Source Type: news

Eliminating hepatitis C in Pakistan could yield a return-on-investment of US$9.10 billion
Pakistan has one of the highest rates of hepatitis C virus (HCV) infection in the world, accounting for over ten per cent of global HCV infections. A new modelling study led by the University of Bristol, UK, suggests that achieving the World Health Organization goal of eliminating HCV as a public health problem by 2030 in Pakistan is likely to be highly cost-effective by 2030, cost-saving by 2031, and could deliver US$9.10 billion in savings to the Pakistan national economy by 2050. (Source: University of Bristol news)
Source: University of Bristol news - October 22, 2021 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Institutes, Bristol Population Health Science Institute; Press Release Source Type: news

Scientists Successfully Attached a Pig Kidney to Human For the First Time
Scientists temporarily attached a pig’s kidney to a human body and watched it begin to work, a small step in the decades-long quest to one day use animal organs for life-saving transplants. Pigs have been the most recent research focus to address the organ shortage, but among the hurdles: A sugar in pig cells, foreign to the human body, causes immediate organ rejection. The kidney for this experiment came from a gene-edited animal, engineered to eliminate that sugar and avoid an immune system attack. Surgeons attached the pig kidney to a pair of large blood vessels outside the body of a deceased recipient so they cou...
Source: TIME: Health - October 20, 2021 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Research wire Source Type: news

Scientists Successfully Attached a Pig Kidney to Human For the First Time
Scientists temporarily attached a pig’s kidney to a human body and watched it begin to work, a small step in the decades-long quest to one day use animal organs for life-saving transplants. Pigs have been the most recent research focus to address the organ shortage, but among the hurdles: A sugar in pig cells, foreign to the human body, causes immediate organ rejection. The kidney for this experiment came from a gene-edited animal, engineered to eliminate that sugar and avoid an immune system attack. Surgeons attached the pig kidney to a pair of large blood vessels outside the body of a deceased recipient so they cou...
Source: TIME: Science - October 20, 2021 Category: Science Authors: Carla K. Johnson / AP Tags: Uncategorized Research wire Source Type: news

Framing public health response to the opioid and overdose crisis: are there alternatives to cascade of care model? - H øj SB, Bruneau J, Hickman M.
The 'cascade of care' has seen widespread uptake as a framework for measuring patient engagement in care for chronic conditions including HIV, hepatitis C and diabetes.1 Attention recently turned to its potential utility in the field of addiction care, par... (Source: SafetyLit)
Source: SafetyLit - October 11, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

American Scientists Win Nobel Prize in Medicine for Research on Human Sensory Receptors
(STOCKHOLM) — Two scientists won the Nobel Prize in medicine on Monday for their discoveries into how the human body perceives temperature and touch, revelations that could lead to new ways of treating pain or even heart disease. Americans David Julius and Ardem Patapoutian identified receptors in the skin that respond to heat and pressure. Their work is focused on the field of somatosensation, which explores the ability of specialized organs such as eyes, ears and skin to see, hear and feel. “This really unlocks one of the secrets of nature,” said Thomas Perlmann, secretary-general of the Nobel Committee...
Source: TIME: Health - October 4, 2021 Category: Consumer Health News Authors: AP / David Keyton and Frank Jordans Tags: Uncategorized medicine wire Source Type: news

Patients with chronic hepatitis C have high out-of-pocket costs in Canada
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2021 Category: Drugs & Pharmacology Source Type: news

Replacing Monopolies with Impact Rewards
This article was originally published by OpenGlobalRights (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - September 24, 2021 Category: International Medicine & Public Health Authors: Thomas Pogge Tags: Economy & Trade Global Global Governance Headlines Health Human Rights TerraViva United Nations Source Type: news

NIAID Scientists Find a Key to Hepatitis C Entry into Cells
Understanding Structure of HCV Proteins Could Aid in Vaccine Development. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 21, 2021 Category: American Health Source Type: news

Gilead Sciences considered Atlanta, Durham before selecting Raleigh for 275 jobs
The maker of breakthrough HIV, hepatitis C and cancer therapies — as well as the Covid drug remdesivir — snagged nearly $10 million reimbursement incentive and more than $357,000 in community college training incentives from North Carolina. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 16, 2021 Category: American Health Authors: Lauren Ohnesorge Source Type: news

Vaccine Access Negotiations to Resume as New Variants Spread
Vaccine access negotiations are at critical juncture. While many countries support the intellectual property rights waiver, including the European parliament the European Union does not. Credit: PAHO/Karen GonzálezBy Lyndal RowlandsMelbourne, Australia , Aug 30 2021 (IPS) A committee that has spent almost a year negotiating the terms of a temporary intellectual property waiver for Covid-19 medicines will reconvene in September after pausing for the European Summer. As new variants spread rapidly around the world, the deadlock in the World Trade Organization Trade-Related Aspects of Intellectual Property Rights (TRI...
Source: IPS Inter Press Service - Health - August 30, 2021 Category: International Medicine & Public Health Authors: Lyndal Rowlands Tags: COVID-19 Development & Aid Economy & Trade Featured Global Headlines Health Humanitarian Emergencies TerraViva United Nations COVAX COVID-19 vaccines TRIPS. WTO Source Type: news

Pamela Anderson health: Bay Watch star's 'death sentence' diagnosis - symptoms
FORMER BAYWATCH star Pamela Anderson has made a name for herself wearing a skimpy red bikini, but her health took a worrying turn when she contracted hepatitis C. (Source: Daily Express - Health)
Source: Daily Express - Health - August 30, 2021 Category: Consumer Health News Source Type: news

Hepatitis C treatment for children
Children in England are set to be the first in the world to be offered a cure for hepatitis C, as part of NHS plans to eradicate the disease entirely. (Source: NHS Networks)
Source: NHS Networks - August 25, 2021 Category: UK Health Source Type: news

Mayo Clinic Q & amp;A podcast: Expanding the donor pool - hepatitis C no longer a barrier to transplant
With a goal of shortening the wait time for a solid organ transplant, Mayo Clinic is leading efforts to expand the donor pool by making more organs suitable for transplantation. Organs from deceased donors are screened thoroughly, and donated organs that tested positive for hepatitis C were previously discarded. But research at Mayo Clinic has changed that. A recent Mayo Clinic study found that livers from donors exposed to hepatitis C can be safely used… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 23, 2021 Category: Databases & Libraries Source Type: news

Scientists reveal blueprint for getting hepatitis C treatment to people who inject drugs
Scientists have revealed a new method of delivering hepatitis C testing and treatment to people who inject drugs which will help bring the world a step closer to eliminating the virus. (Source: University of Bristol news)
Source: University of Bristol news - August 11, 2021 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences; Press Release Source Type: news

Machine learning takes a village: assessing neighbourhood-level vulnerability for an overdose and infectious disease outbreak - Yedinak JL, Li Y, Krieger MS, Howe K, Ndoye CD, Lee H, Civitarese AM, Marak T, Nelson E, Samuels EA, Chan PA, Bertrand T, Marshall BDL.
BACKGROUND: Multiple areas in the United States of America (USA) are experiencing high rates of overdose and outbreaks of bloodborne infections, including HIV and hepatitis C virus (HCV), due to non-sterile injection drug use. We aimed to identify neighbou... (Source: SafetyLit)
Source: SafetyLit - August 6, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Recognizing Hepatitis R & D on World Hepatitis Day
Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. There are five main hepatitis viruses, with types A, B, C most common. In 2018, the Centers for Disease Control and Prevention estimated that Americans were infected with 24,900 cases of hepatitis A and 21,600 cases of hepatitis B, many of which go undiagnosed because individuals do not know they are infected. Over the past several years, the biopharmaceutical industry has made significant progress in bringing medicines to patients that improve cure rates, reduce side effects and duration of treatment and expand treatment options. (Source: The Catalyst)
Source: The Catalyst - July 28, 2021 Category: Pharmaceuticals Tags: Research and Development Drug Cost Hepatitis C Source Type: news

Screening at a Federally Qualified Health Center in the Midwest for Hepatitis C Among People Who Inject Drugs, 2019-2020
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - July 15, 2021 Category: International Medicine & Public Health Tags: Public Health Source Type: news

The Cedar Project: exploring the role of colonial harms and childhood maltreatment on HIV and hepatitis C infection in a cohort study involving young Indigenous people who use drugs in two Canadian cities - Pearce ME, Jongbloed K, Pooyak S, Christian WM, Teegee MGWWM, Caron NR, Thomas V, Henderson E, Zamar D, Yoshida EM, Schechter MT, Spittal PM.
This study examined associations between childhood maltreatment, colonial harms and sex/drug-related risks for HIV and hepatitis C virus (HCV) infection among young Indigenous people who use drugs. DESIGN: The Cedar Project is a cohort ... (Source: SafetyLit)
Source: SafetyLit - July 12, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Hepatitis C vaccine could be rolled out within five years, says Nobel Prize winner who discovered virus
(European Society of Clinical Microbiology and Infectious Diseases) A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other scientists for discovering the hepatitis C virus (HCV) in 1989. Sir Michael will discuss the development of a vaccine in a special presentation at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 11, 2021 Category: International Medicine & Public Health Source Type: news

Appeals court upholds rationing of hepatitis C treatment
The Kentucky Department of Corrections can deny a life-saving but expensive hepatitis C medication to inmates (Source: ABC News: Health)
Source: ABC News: Health - July 10, 2021 Category: Consumer Health News Tags: Health Source Type: news

Rapid Hepatitis C Test Could Improve Diagnosis, Treatment
A simpler version of a test for the hepatitis C virus (HCV) may open testing to people in areas where medical care is limited. (Source: WebMD Health)
Source: WebMD Health - July 8, 2021 Category: Consumer Health News Source Type: news

Hepatitis C Antivirals May Fight SARS-CoV-2 Hepatitis C Antivirals May Fight SARS-CoV-2
Sofosbuvir/ledipasvir and nitazoxanide both appeared to clear SARS-CoV-2 infections in a preliminary trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2021 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

New Program to Develop Antivirals for COVID-19 New Program to Develop Antivirals for COVID-19
The Antiviral Program for Pandemics will allow the NIH to focus on antivirals for COVID-19 and other pandemic risks, including hemorrhagic fever and influenza, the way HIV and hepatitis C can be managed.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - June 17, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Hepatitis C Related Cognitive Impairment Hepatitis C Related Cognitive Impairment
This study assessed the prevalence and predictors of HCV-related cognitive impairment. Can it be reversed by anti-viral therapy?Journal of Viral Hepatitis (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - June 15, 2021 Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news

Malaysia registers first hepatitis C treatment developed through South-South cooperation
(Drugs for Neglected Diseases Initiative) New treatment combination for hepatitis C virus (HCV) is an additional affordable option for millions still waiting for access to lifesaving treatments in middle-income countries. Combination is safe and effective, including for hard-to-treat cases and people with HCV and HIV. New drug ravidasvir is the first HCV drug to be developed through South-South collaboration and with support from non-profit organizations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2021 Category: International Medicine & Public Health Source Type: news

U.S. Food and Drug Administration Approves New Formulation of Epclusa, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun. 10, 2021-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion of the pediatric indication of Epclusa (sofosbuvir/velpatasvir) for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 10, 2021 Category: Drugs & Pharmacology Source Type: news

Liver Transplant Outcomes Improving for US Patients With HIV/HCV Liver Transplant Outcomes Improving for US Patients With HIV/HCV
Hepatitis C virus (HCV) infection no longer confers worse patient survival in the era of direct-acting antiviral therapy, but the population remains underserved.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - May 28, 2021 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Africa: President Sisi Keen On Helping Africa Eradicate Hepatitis
[Egypt Online] President Abdel Fattah El Sisi is keen on supporting Africa in eliminating hepatitis through an initiative to treat one million Africans for hepatitis C, Health Minister Hala Zayed said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 28, 2021 Category: African Health Source Type: news

MAFLD As a Part of the Global Hepatitis C Elimination Effort MAFLD As a Part of the Global Hepatitis C Elimination Effort
Increasing evidence suggests that metabolic-associated fatty liver disease and chronic hepatitis C frequently coexist, especially in in HCV patients with SVR. What are the implications?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 24, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Wife of patient reacts to blood inquiry statement
Su’s husband Steve was diagnosed with hepatitis C 21 years after first receiving contaminated blood products. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 21, 2021 Category: Consumer Health News Source Type: news

When Medicare chips in on hepatitis C treatment for Medicaid patients, everyone wins
(University of Southern California) USC Schaeffer Center researchers found Medicare has significant financial incentives to partner with Medicaid to treat the majority of hepatitis C cases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 20, 2021 Category: Infectious Diseases Source Type: news

Opt-Out Increases Hepatitis C Screening Uptake
WEDNESDAY, May 19, 2021 -- Twice as many eligible patients get screened for hepatitis C virus (HCV) if it is already ordered for them at the time of a reminder, according to a study published online May 18 in The BMJ. Shivan J. Mehta, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 19, 2021 Category: Pharmaceuticals Source Type: news

Drops in Hepatitis C Testing, Treatment Spark Concern Drops in Hepatitis C Testing, Treatment Spark Concern
Prior to the pandemic, the goal was to eradicate this curable disease. Recent data suggest significant efforts will now be needed to make up for lost ground.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 19, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Drops in Hepatitis C Testing, Treatment
Spark Concern (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 19, 2021 Category: General Medicine Source Type: news

Why Do Patients With Chronic Hepatitis C Drink Alcohol? Why Do Patients With Chronic Hepatitis C Drink Alcohol?
This study examines how sociodemographic factors, chronic pain, and depression relate to the motivations of individuals with chronic HCV to consume alcohol.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Hepatitis C screening doubles when tests ordered ahead of time
(University of Pennsylvania School of Medicine) By sending eligible patients a screening order along with the usual reminder, researchers showed they could double hepatitis C screening rates (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 18, 2021 Category: Infectious Diseases Source Type: news

Hepatitis C Testing, Treatment Down During the Pandemic
MONDAY, May 17, 2021 -- The COVID-19 pandemic reduced routine hepatitis C virus (HCV) testing and treatment, according to a study published online May 10 in the American Journal of Preventive Medicine. Harvey W. Kaufman, M.D., from Quest... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2021 Category: Pharmaceuticals Source Type: news

Africa: New Drugs Work Against the Many Strains of Hepatitis C Found in African Countries
[The Conversation Africa] Around the world, 71 million people have been infected with the hepatitis C virus. The primary route of infection is through direct contact with another person's blood. This means the virus can be transmitted in a number of ways, including intravenous drug use, tattooing, contaminated blood or blood products and surgical procedures. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 2, 2021 Category: African Health Source Type: news

Ravidasvir-Sofosbuvir Combo Promising in Hep C Infection Ravidasvir-Sofosbuvir Combo Promising in Hep C Infection
A combination of ravidasvir and sofosbuvir appears to be an effective treatment for chronic hepatitis C virus infection across a diverse pool of patients who took part in a trial underway in Malaysia and Thailand.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 29, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Hepatitis C drugs multiply effect of COVID-19 antiviral Remdesivir
When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19. Published this week in Cell Reports, this finding - from Gaetano Montelione, a professor of chemistry and chemical biology at Rensselaer Polytechnic Institute, and his collaborators at the Icahn School of Medicine at Mount Sinai and the University of Texas at Austin - raises the potential for repurposing available drugs as COVID-19 antivirals in cases where a vaccine isn't practical or effective. (Source: World Pharma News)
Source: World Pharma News - April 27, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news